EssilorLuxottica to acquire Optegra clinics, another leap forward in its med-tech strategy

Core Insights - EssilorLuxottica has entered into an agreement to acquire Optegra, a leading ophthalmology platform operating in five European markets, enhancing its med-tech strategy [2][3] - The acquisition will integrate advanced diagnostics, therapeutic interventions, and surgical treatments into a seamless platform, leveraging AI and big data capabilities [5][7] - Optegra operates over 70 eye hospitals and diagnostic facilities, providing a range of ophthalmic treatments and elective procedures, establishing a strong reputation for quality care [4][6] Company Strategy - The acquisition represents a significant milestone in EssilorLuxottica's strategy to expand beyond traditional eyewear into comprehensive eyecare solutions [3][5] - The partnership aims to redefine ophthalmic services by combining EssilorLuxottica's global leadership in vision care with Optegra's clinical excellence [7] - The transaction is expected to close later in 2025, pending regulatory approvals [8]